FDA Grants Final Approval To Cipla’s First Generic Somatuline
The Approval Was Based On Cipla’s Abbreviated New Drug Application
Building on a past approval achieved through the 505(b)(2) pathway, the Indian pharma has now secured a further nod from the American regulator for its lead peptide product.
